FLGT · ISSUER CIK 1674930
Fulgent Genetics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 4 Fulgent Genetics, Inc. insiders reported $0.00 of open-market purchases and $117K of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 0 of 4 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$117KInsider selling
−$117KNet open-market
Oct 28, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 202616:18 | Oct 26, 2026 | FLGT | Chief Scientific Officer | F · Tax | $20.22 | −1,645 | 984,472 | -0% | $33K | ||
| Oct 28, 202616:18 | Oct 26, 2026 | FLGT | President and COO | F · Tax | $20.22 | −4,361 | 355,563 | -1% | $88K | ||
| Oct 28, 202616:18 | Oct 26, 2026 | FLGT | CFO and Treasurer | F · Tax | $20.22 | −2,748 | 353,795 | -1% | $56K | ||
| Sep 3, 202619:48 | Sep 1, 2026 | FLGT | CFO and Treasurer | F · Tax | $19.59 | −2,087 | 356,543 | -1% | $41K | ||
| Sep 3, 202619:47 | Sep 1, 2026 | FLGT | Chief Executive Officer, Director, 10% Owner | F · Tax | $19.59 | −4,392 | 885,952 | -0% | $86K | ||
| Sep 3, 202619:47 | Sep 2, 2026 | FLGT | Chief Scientific Officer | S · Sell | $19.66 | −1,673 | 986,117 | -0% | −$33K | ||
| Sep 3, 202619:47 | Sep 2, 2026 | FLGT | President and COO | S · Sell | $19.66 | −2,127 | 359,924 | -1% | −$42K | ||
| Aug 28, 202618:06 | Aug 26, 2026 | FLGT | Chief Executive Officer, Director, 10% Owner | F · Tax | $19.81 | −2,949 | 890,344 | -0% | $58K | ||
| Aug 28, 202618:06 | Aug 26, 2026 | FLGT | CFO and Treasurer | F · Tax | $19.81 | −1,168 | 358,630 | -0% | $23K | ||
| Aug 28, 202618:06 | Aug 27, 2026 | FLGT | President and COO | S · Sell | $19.91 | −1,193 | 362,051 | -0% | −$24K | ||
| Aug 28, 202618:05 | Aug 27, 2026 | FLGT | Chief Scientific Officer | S · Sell | $19.91 | −939 | 987,790 | -0% | −$19K |